These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 33217623

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacokinetics and pharmacodynamics of imipenem during continuous renal replacement therapy in critically ill patients.
    Fish DN, Teitelbaum I, Abraham E.
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2421-8. PubMed ID: 15917542
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Catabolism in critical illness: estimation from urea nitrogen appearance and creatinine production during continuous renal replacement therapy.
    Leblanc M, Garred LJ, Cardinal J, Pichette V, Nolin L, Ouimet D, Geadah D.
    Am J Kidney Dis; 1998 Sep; 32(3):444-53. PubMed ID: 9740161
    [Abstract] [Full Text] [Related]

  • 10. Influence of continuous venovenous hemofiltration and continuous venovenous hemodiafiltration on the disposition of doripenem.
    Cirillo I, Vaccaro N, Balis D, Redman R, Matzke GR.
    Antimicrob Agents Chemother; 2011 Mar; 55(3):1187-93. PubMed ID: 21199922
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aminoglycoside Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
    Krueger CK, Bruno JJ, Tverdek FP, Hernandez M, Abudayyeh A.
    Ann Pharmacother; 2023 Jun; 57(6):629-636. PubMed ID: 36062536
    [Abstract] [Full Text] [Related]

  • 17. Continuous veno-venous hemodiafiltration or hemofiltration: impact on calcium, phosphate and magnesium concentrations.
    Morimatsu H, Uchino S, Bellomo R, Ronco C.
    Int J Artif Organs; 2002 Jun; 25(6):512-9. PubMed ID: 12117290
    [Abstract] [Full Text] [Related]

  • 18. Cefepime and continuous renal replacement therapy (CRRT): in vitro permeability of two CRRT membranes and pharmacokinetics in four critically ill patients.
    Isla A, Gascón AR, Maynar J, Arzuaga A, Toral D, Pedraz JL.
    Clin Ther; 2005 May; 27(5):599-608. PubMed ID: 15978309
    [Abstract] [Full Text] [Related]

  • 19. Outcomes of sustained low efficiency dialysis versus continuous renal replacement therapy in critically ill adults with acute kidney injury: a cohort study.
    Kitchlu A, Adhikari N, Burns KE, Friedrich JO, Garg AX, Klein D, Richardson RM, Wald R.
    BMC Nephrol; 2015 Aug 04; 16():127. PubMed ID: 26238520
    [Abstract] [Full Text] [Related]

  • 20. Pharmacokinetics of cefepime during continuous renal replacement therapy in critically ill patients.
    Malone RS, Fish DN, Abraham E, Teitelbaum I.
    Antimicrob Agents Chemother; 2001 Nov 04; 45(11):3148-55. PubMed ID: 11600370
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.